Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-129447)

Filing Details

Accession Number:: 0001209191-16-129447
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-24 07:34:41
Reporting Period:: 2016-06-22

Filing Date:: 2016-06-24
Accepted Time:: 2016-06-24 07:34:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1272353	David Lawrence	420 Saw Mill River Road Ardsley NY 10502	Chief Of Business Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-22	500	$8.50	9,702	No	4	M	Direct
Common Stock	Disposition	2016-06-22	500	$25.09	9,202	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2016-06-22	500	$0.00	500	$8.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-09-25	No	4	M	Direct

Footnotes

Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2016 on the expiration date reported withinTable II unless exercised.
The shares subject to these options vested in installments and were fully vested on September 25, 2010.